Skip to main content
Clinical Trials/NCT03269708
NCT03269708
Active, not recruiting
Not Applicable

Improving Cardiac Secondary Prevention Through Personalized Biomarker Knowledge

Western University, Canada1 site in 1 country200 target enrollmentMarch 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Myocardial Infarction
Sponsor
Western University, Canada
Enrollment
200
Locations
1
Primary Endpoint
Exercise capacity based on cardiopulmonary exercise testing
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

The purpose of this study is to determine whether providing individuals with personalized information on cellular aging, including telomere length, will stimulate them to adhere to cardiac prevention strategies and improve exercise capacity.

Detailed Description

Individuals who have sustained a heart attack are at considerable risk for future cardiac events. A cardiac rehabilitation and exercise program can reduce this risk but it remains a challenge to adopt optimum lifestyle changes. We will determine whether providing individuals with information on leukocyte telomere length, will motivate them to improve their exercise performance. We will test whether professionally conveying this information will stimulate an individual to adhere to proven cardiac prevention strategies, looking at the extent to which one's exercise capacity improves over time.

Registry
clinicaltrials.gov
Start Date
March 1, 2019
End Date
September 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Western University, Canada
Responsible Party
Principal Investigator
Principal Investigator

Geoffrey Pickering MD PhD

Professor

Western University, Canada

Eligibility Criteria

Inclusion Criteria

  • Individuals who have sustained a myocardial infarction and entered the cardiac rehabilitation program

Exclusion Criteria

  • Individuals with genetic mutations that affect telomere length
  • Individuals who may not have the mental capacity to understanding the ramifications of risk biomarkers

Outcomes

Primary Outcomes

Exercise capacity based on cardiopulmonary exercise testing

Time Frame: after 6-month cardiac rehabilitation program

Online VO2 maximum

Secondary Outcomes

  • Adherence to supervised exercise sessions(6 months)
  • Activity assessment(6 months)

Study Sites (1)

Loading locations...

Similar Trials